Grass Allergy Pill a First for US Sufferers

Wednesday, 02 Apr 2014 07:05 AM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
France's Stallergenes has received U.S. regulatory approval to sell the first immunotherapy pill against grass allergies in the world's biggest pharmaceutical market, sending its shares up 6 percent on Wednesday.
 
Stallergenes has said it sees a potential U.S. market of nearly 3 million patients that will eventually be worth $1 billion in annual sales for these types of drugs.
 
"That's very positive news as the group is considerably expanding its market," Gilbert Dupont analysts wrote in a note.
 
Oralair is a fast-dissolving tablet to be placed under the tongue that contains extracts from five types of grass pollen: sweet vernal, orchard, perennial rye, timothy and Kentucky bluegrass. It harnesses the immune system to alleviate allergies and is an alternative to current treatments that need to be injected.
 
Merck and Danish partner ALK Abello are also expected to launch their rival therapy Grastek in the United States this year. In December, both drugs received strong recommendations from outside advisers to the U.S. Food and Drug Administration (FDA).
 
Oralair was approved in the European Union in 2008 and is also sold in Canada, Australia and Russia for the treatment of grass pollen allergy. It generated revenue of 22.2 million euros ($30.5 million) in 2013, up 37 percent from 2012.

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
Top Stories
You May Also Like

Way You Walk Can Reveal If You're Getting Alzheimer's

Thursday, 02 Oct 2014 09:48 AM

Memory loss is not always the first sign of Alzheimer's disease. New research suggests problems in the way older people  . . .

Acupuncture Doesn't Relieve Knee Pain: Study

Thursday, 02 Oct 2014 08:20 AM

Acupuncture doesn't improve knee pain any more than sham acupuncture, according to a new study.
Among patients o . . .

New Type of Clinic Eyed to Help Stop Ebola

Thursday, 02 Oct 2014 08:12 AM

Britain and Sierra Leone are appealing for more help to slow the biggest ever Ebola outbreak - and are proposing a new t . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved